Danilkovitch Alla 4
4 · OSIRIS THERAPEUTICS, INC. · Filed Sep 28, 2017
Insider Transaction Report
Form 4
Danilkovitch Alla
Chief Scientific Officer
Transactions
- Award
Non-qualified Stock Option (right to buy)
2017-07-19$6.80/sh+15,466$105,169→ 139,000 totalExercise: $6.80From: 2018-07-19Exp: 2027-07-19→ Common Stock (15,466 underlying) - Award
Incentive Stock Option (right to buy)
2017-07-19$6.80/sh+34,534$234,831→ 125,534 totalExercise: $6.80From: 2018-07-19Exp: 2027-07-19→ Common Stock (34,534 underlying)
Footnotes (1)
- [F1]25% of the shares underlying this option shall vest on each of July 19, 2018, July 19, 2019, July 19, 2020 and July 19, 2021, subject to Reporting Person's continued service through the applicable vesting date.